CNA Blog— From the Experts

Bringing life-changing drugs and medical devices to market involves a number of specialist life science companies working together to research, design, trial, manufacture and distribute new products.

Fiduciary liability coverage can be easily misunderstood, resulting in costly lawsuits.

Biometric identification, the use of unique physical or behavioural characteristics to identify individuals, has been around for decades. With advances in technology, biometric authentication is now part of everyday life.

At CNA, we understand the importance of fostering an organizational culture that celebrates individuals’ differences, attracts diverse talent, and inspires a work environment that enables all employees to do their best work.

CNA has always focused on our employees’ physical and mental needs, but the COVID-19 pandemic presented new challenges that required additional solutions.

Like any other pharmaceutical, a COVID-19 vaccine must be proven safe and effective through clinical trials. Another challenge however, lies in the logistics of distributing the vaccines globally.

For brokers, one of the easiest ways to ensure that the right solution is being provided to a client is to make sure that the terms are fully understood. Here is a solution to insure peace of mind.

As specialty risks evolve, businesses need to re-evaluate their exposures and ensure they are adequately protected.

Today’s business world operates on an international scale. Consumers no longer rely solely on locally produced goods and services, and companies continue to expand operations worldwide for increased efficiency or access to new markets and supplies.

The use of any technology platform comes with risk, and each healthcare provider must carefully identify the risks to their practice and their patients, mitigate these risks, and have the appropriate insurance coverage in place.